CORE

🇺🇦   make metadata, not war

    2 research outputs found

    901f Efficacy and Safety of Grazoprevir/Elbasvir ± Ribavirin (RBV) for 12 or 16 Weeks in Patients With HCV G1, G4, or G6 Infection Who Previously Failed Peginterferon/RBV: C-EDGE Treatment-Experienced Trial

    Author
    Publication venue
    'Elsevier BV'
    Publication date
    Field of study
    No full text
    Crossref

    A Large Cohort Comparison of the New 2014 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria with the 2005 Version in Severely Affected Patients

    Author
    Publication venue
    'Elsevier BV'
    Publication date
    Field of study
    No full text
    Crossref
    corecore